Outcomes for Patients With Diabetes After Continuous-Flow Left Ventricular Assist Device Implantation
Diabetes mellitus (DM) affects an estimated 366 million people worldwide, and confers a markedly increased risk of cardiovascular disease, including coronary artery disease (CAD), stroke, and HF.1 Diabetes is an independent mortality risk factor for HF patients at follow-up intervals of 1 –8 years.2–5 Decompensated HF is an insulin-resistant state, promoting hyperglycemia in patients with and without DM. Independently from DM status, blood glucose level at HF hospital admission is prognostic for 30-day mortality.
Source: Journal of Cardiac Failure - Category: Cardiology Authors: Amanda R. Vest, Stanley M. Mistak, Rory Hachamovitch, Maria M. Mountis, Nader Moazami, James B. Young Tags: Clinical Investigation Source Type: research
More News: Cardiology | Cardiovascular | Diabetes | Diabetes Mellitus | Endocrinology | Heart | Hospitals | Insulin | Stroke